Tag: Marea Therapeutics

Marea Therapeutics has filed a notice of an exempt offering of securities to raise $160,418,629.00 in New Equity Investment.

Marea Therapeutics has filed a notice of an exempt offering of securities to raise $160,418,629.00 in New Equity Investment.

According to filings with the U.S. Securities and Exchange Commission, Marea Therapeutics is raising up to $160,418,629.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Josh Lehrer played a…

Read More Read More

Marea Therapeutics Launches with $190 Million to Accelerate a New Generation of Medicines for Cardiometabolic Diseases

Marea Therapeutics Launches with $190 Million to Accelerate a New Generation of Medicines for Cardiometabolic Diseases

Leveraging large-scale human genetics to advance clinical-stage pipeline of first-in-class treatments that target critical, unaddressed and genetically validated causes of cardiometabolic diseases Lead program, MAR001, is a first-in-class ANGPTL4 inhibitor in Phase 2 clinical development…

Read More Read More